Bottom line
Is REFA a good fund? The bottom line
REFA is a managed international stock ETF from Columbia Threadneedle.
It charges 0.32% — about $32 a year on every $10,000 invested, cheaper than 90% of international stock funds we track.
With $5.6 million in net assets and 212 holdings, its largest position is ASML Holding NV (4.3%) and the top 10 make up 25.9% of the portfolio.
The closest lower-cost alternative we found is FENI (0.28%, 52% top-holdings overlap).
What stands out
- Low cost: cheaper than 90% of international stock peers
- Broadly diversified (212 holdings)
What to watch
- Small fund ($5.6 million) — small funds are likelier to close
Updated Nov 19, 2026
What REFA invests in
Columbia Research Enhanced International Equity ETF (the Fund) seeks investment results that, before fees and expenses, closely correspond to the performance of the Beta Advantage Research Enhanced International Equity Index (the Index).
The Fund is an exchange-traded fund (ETF) that seeks to track the performance of the Beta Advantage Research Enhanced International Equity Index (the Index). Under normal circumstances, the Fund invests at least 80% of its net assets ( plus the amount of any borrowings for investment purposes) in equity securities (including, but not limited to, common shares traded on local exchanges, American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs)) of companies located in international developed market countries. International developed market countries are those included in the Solactive GBS Developed Markets ex North America Large & Mid Cap USD Index (also referred to as the Starting Universe). The Index reflects a rules-based strategic beta approach to investing in the companies that comprise the Starting Universe, with the Index designed to seek to achieve stronger total…
From the fund's prospectus (filed Jul 24, 2026).
What REFA costs
On a $10,000 investment, REFA's 0.32% expense ratio costs about $32 a year. The median international stock fund charges 0.9%.
REFA top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | ASML Holding NV | 4.33% |
| 2 | Roche Holding AG | 3.05% |
| 3 | Novartis AG | 2.99% |
| 4 | BHP Group Ltd | 2.92% |
| 5 | Tokyo Electron Ltd | 2.53% |
| 6 | HSBC Holdings PLC | 2.25% |
| 7 | Hitachi Ltd | 2.15% |
| 8 | Siemens Energy AG | 1.99% |
| 9 | Safran SA | 1.92% |
| 10 | Fast Retailing Co Ltd | 1.81% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 25.9% of the fund. See all top 25 holdings and asset mix →